413 related articles for article (PubMed ID: 17416967)
21. Neurotoxicity induces cleavage of p35 to p25 by calpain.
Lee MS; Kwon YT; Li M; Peng J; Friedlander RM; Tsai LH
Nature; 2000 May; 405(6784):360-4. PubMed ID: 10830966
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia increases Aβ-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice.
Gao L; Tian S; Gao H; Xu Y
J Mol Neurosci; 2013 Sep; 51(1):138-47. PubMed ID: 23345083
[TBL] [Abstract][Full Text] [Related]
23. Amyloid beta-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation.
Reifert J; Hartung-Cranston D; Feinstein SC
J Biol Chem; 2011 Jun; 286(23):20797-811. PubMed ID: 21482827
[TBL] [Abstract][Full Text] [Related]
24. Dopamine D1 receptor activation induces tau phosphorylation via cdk5 and GSK3 signaling pathways.
Lebel M; Patenaude C; Allyson J; Massicotte G; Cyr M
Neuropharmacology; 2009 Sep; 57(4):392-402. PubMed ID: 19591849
[TBL] [Abstract][Full Text] [Related]
25. Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation.
Han P; Dou F; Li F; Zhang X; Zhang YW; Zheng H; Lipton SA; Xu H; Liao FF
J Neurosci; 2005 Dec; 25(50):11542-52. PubMed ID: 16354912
[TBL] [Abstract][Full Text] [Related]
26. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.
Zheng YL; Kesavapany S; Gravell M; Hamilton RS; Schubert M; Amin N; Albers W; Grant P; Pant HC
EMBO J; 2005 Jan; 24(1):209-20. PubMed ID: 15592431
[TBL] [Abstract][Full Text] [Related]
27. Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid.
Tsai SY; Pokrass MJ; Klauer NR; Nohara H; Su TP
Proc Natl Acad Sci U S A; 2015 May; 112(21):6742-7. PubMed ID: 25964330
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
29. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
Lopes JP; Oliveira CR; Agostinho P
Aging Cell; 2010 Feb; 9(1):64-77. PubMed ID: 19895631
[TBL] [Abstract][Full Text] [Related]
30. A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons.
Alvarez A; Muñoz JP; Maccioni RB
Exp Cell Res; 2001 Apr; 264(2):266-74. PubMed ID: 11262183
[TBL] [Abstract][Full Text] [Related]
31. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
32. S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion.
Won JS; Annamalai B; Choi S; Singh I; Singh AK
Brain Res; 2015 Oct; 1624():359-369. PubMed ID: 26271717
[TBL] [Abstract][Full Text] [Related]
33. Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus.
Crespo-Biel N; Canudas AM; Camins A; Pallàs M
Neurochem Int; 2007 Jan; 50(2):435-42. PubMed ID: 17116346
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effect of TNFalpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase.
Orellana DI; Quintanilla RA; Maccioni RB
Biochim Biophys Acta; 2007 Feb; 1773(2):254-63. PubMed ID: 17150266
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of tau aggregation by cdk5 and GSK3β.
Lee S; Hall GF; Shea TB
J Alzheimers Dis; 2011; 26(2):355-64. PubMed ID: 21677377
[TBL] [Abstract][Full Text] [Related]
36. Dendritic distribution of CDK5 mRNA and p35 mRNA, and a glutamate-responsive increase of CDK5/p25 complex contribute to tau hyperphosphorylation.
Tanaka T; Ohashi S; Takashima A; Kobayashi S
Biochim Biophys Acta Gen Subj; 2022 Jul; 1866(7):130135. PubMed ID: 35358667
[TBL] [Abstract][Full Text] [Related]
37. [Ginsenoside Rb1 attenuates beta-amyloid peptide(25-35) -induced hyperphosphorylation of tau protein through CDK5 signal pathway].
Xie YH; Chen XC; Zhang J; Huang TW; Song JQ; Fang YX; Pan XD; Lin ZY
Yao Xue Xue Bao; 2007 Aug; 42(8):828-32. PubMed ID: 17944229
[TBL] [Abstract][Full Text] [Related]
38. Mice lacking phosphatase PP2A subunit PR61/B'delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta.
Louis JV; Martens E; Borghgraef P; Lambrecht C; Sents W; Longin S; Zwaenepoel K; Pijnenborg R; Landrieu I; Lippens G; Ledermann B; Götz J; Van Leuven F; Goris J; Janssens V
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6957-62. PubMed ID: 21482799
[TBL] [Abstract][Full Text] [Related]
39. RPS23RG1 modulates tau phosphorylation and axon outgrowth through regulating p35 proteasomal degradation.
Zhao D; Zhou Y; Huo Y; Meng J; Xiao X; Han L; Zhang X; Luo H; Can D; Sun H; Huang TY; Wang X; Zhang J; Liu FR; Xu H; Zhang YW
Cell Death Differ; 2021 Jan; 28(1):337-348. PubMed ID: 32908202
[TBL] [Abstract][Full Text] [Related]
40. Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39.
Minegishi S; Asada A; Miyauchi S; Fuchigami T; Saito T; Hisanaga S
Biochemistry; 2010 Jul; 49(26):5482-93. PubMed ID: 20518484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
